Create account

Coverage dated July 1, 2024 to July 2, 2024

FDA approves Eli Lilly Alzheimer's drug, which can modestly slow disease

Headline from NBC10 Philadelphia

U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the...

NBC10 Philadelphia's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

55 articles, oldest first.

  1. WHDH Boston

    FDA approves a second Alzheimer’s drug that can modestly slow disease - Boston News, Weather, Sports (opens WHDH Boston)

    Published

    WHDH Boston's feed description

    WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of

  2. New York Post

    FDA approves Eli Lilly Alzheimer’s drug that slows progress of the disease (opens New York Post)

    Published

    New York Post's feed description

    The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's LLY.N donanemab for patients with early Alzheimer's, making it the second approved drug for slowing the progress of the brain-wasting disease.

  3. MedicalXpress

    FDA approves new drug to treat Alzheimer (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    A new drug to treat Alzheimer

  4. Kokomo Tribune

    FDA approves a second Alzheimer's drug that can modestly slow disease (opens Kokomo Tribune)

    Published

    Kokomo Tribune's feed description

    U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It

  5. NBC News

    FDA approves new Alzheimer’s treatment that slows decline in memory (opens NBC News)

    Published

    NBC News's feed description

    The FDA approved a new Alzheimer’s drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities.

  6. New York Times

    New Drug Approved for Early Alzheimer’s (opens New York Times)

    Published

    New York Times's feed description

    The drug, by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

  7. WSVN Miami

    FDA approves a second Alzheimer’s drug that can modestly slow disease - WSVN 7News | Miami News, Weather, Sports (opens WSVN Miami)

    Published

    WSVN Miami's feed description

    U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the

  8. Fox32 Chicago

    FDA approves Eli Lilly's Alzheimer's drug that can modestly slow disease (opens Fox32 Chicago)

    Published

    Fox32 Chicago's feed description

    Eli Lilly's Kisunla is the second treatment available in the U.S. that has been shown in trials to modestly slow a decline in memory.

  9. Honolulu Star-Advertiser

    Eli Lilly Alzheimer’s drug approved by the FDA | Honolulu Star-Advertiser (opens Honolulu Star-Advertiser)

    Published

    Honolulu Star-Advertiser's feed description

    The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s treatment for early Alzheimer’s, making it the second therapy for slowing the progression of the brain-wasting disease that will be available to U.S. patients.

  10. FOX 5 DC

    New Alzheimer’s drug that can modestly slow disease approved by FDA (opens FOX 5 DC)

    Published

    FOX 5 DC's feed description

    U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.

  11. WHEC Rochester

    FDA approves a second Alzheimer’s drug that can slow the disease by several months (opens WHEC Rochester)

    Published

    WHEC Rochester's feed description

    WASHINGTON (AP) — FDA approves a second Alzheimer’s drug that can slow the disease by several months.

  12. Time

    FDA Approves Second Alzheimer's Drug That Can Modestly Slow Disease (opens Time)

    Published

    Time's feed description

    The Food and Drug Administration approved Eli Lilly’s Kisunla for mild or early cases of dementia caused by Alzheimer’s.

  13. WMUR

    Alzheimer's drug approved by FDA that can modestly slow disease (opens WMUR)

    Published

    WMUR's feed description

    It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s approval of a similar drug.

  14. The Guardian

    FDA approves second Alzheimer’s drug that can slow onset of disease (opens The Guardian)

    Published

    The Guardian's feed description

    Eli Lilly says Kisunla demonstrated ‘meaningful results’ for people showing early symptoms of the disease

  15. Forbes

    FDA Approves Eli Lilly’s Alzheimer’s Drug Donanemab (opens Forbes)

    Published

    Forbes's feed description

    The monthly injection showed “very meaningful results” in slowing cognitive decline, the company said.

  16. NBC10 Philadelphia

    FDA approves Eli Lilly Alzheimer's drug, which can modestly slow disease (opens NBC10 Philadelphia)

    Published

    NBC10 Philadelphia's feed description

    U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the...

  17. Science Alert

    FDA Approves Eli Lilly's New Alzheimer's Drug For Early Disease Symptoms (opens Science Alert)

    Published

    Science Alert's feed description

    The US Food and Drug Administration (FDA) approved a drug made by Eli Lilly on Tuesday that is designed to treat the early symptoms of Alzheimer's disease.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

FDA approves Eli Lilly Alzheimer's drug, which can modestly slow disease | Since Then